Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
NeuBase Therapeutics is a biotechnology business based in the US. NeuBase Therapeutics stocks (NBSE.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.76 – a decrease of 3.44% over the previous week. NeuBase Therapeutics employs 33 staff and has a market cap (total outstanding stock value) of $32.3 million.
Finder's Pick for
Beginners
Finder's Pick for
Free Trades
Finder's Pick for
Commodity Stocks
Finder's Pick for
Global Trading
| Latest market close | $0.97 |
|---|---|
| 52-week range | $0.89 - $5.51 |
| 50-day moving average | $1.49 |
| 200-day moving average | $2.56 |
| Wall St. target price | $13.25 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.04 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $0.9656 from 2022-05-25
| 1 week (2022-05-17) | -6.25% |
|---|---|
| 1 month (2022-04-23) | N/A |
| 3 months (2022-02-23) | N/A |
| 6 months (2021-11-26) | -68.85% |
| 1 year (2021-05-27) | -81.82% |
|---|---|
| 2 years (2020-05-27) | -87.84% |
| 3 years (2019-05-24) | 3.04 |
| 5 years (2017-05-26) | 55.74% |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -54.47% |
| Return on equity TTM | -107.81% |
| Profit margin | 0% |
| Book value | $1.18 |
| Market capitalisation | $32.3 million |
TTM: trailing 12 months
We're not expecting NeuBase Therapeutics to pay a dividend over the next 12 months.
NeuBase Therapeutics's shares were split on a 1:20 basis on 4 February 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NeuBase Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for NeuBase Therapeutics shares which in turn could have impacted NeuBase Therapeutics's share price.
Over the last 12 months, NeuBase Therapeutics's shares have ranged in value from as little as $0.89 up to $5.51. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NeuBase Therapeutics's is 0.7655. This would suggest that NeuBase Therapeutics's shares are less volatile than average (for this exchange).
NeuBase Therapeutics, Inc. , a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1; NT0300, a PATrOL-enabled therapeutic treatment to target the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania. .
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.
Read more…
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
Read more…
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.
Read more…Learn more about apps like Wealthsimple to find the best trading platform for your unique set of needs.
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.
Steps to owning and managing ENT stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing KAMBI stock, with 24-hour and historical pricing before you buy.
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
Steps to owning and managing RSI stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing PBTHF stock, with 24-hour and historical pricing before you buy.
Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
Everything we know about the Actelis Networks IPO, plus information on how to buy in.
